Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 174

1.

Exosome-derived microRNA-22 ameliorates pulmonary fibrosis by regulating fibroblast-to-myofibroblast differentiation both in vitro and in vivo.

Kuse N, Kamio K, Azuma A, Matsuda K, Inomata M, Usuki J, Morinaga A, Tanaka T, Kashiwada T, Atsumi K, Hayashi H, Saito Y, Seike M, Gemma A.

J Nippon Med Sch. 2019 Nov 28. doi: 10.1272/jnms.JNMS.2020_87-302. [Epub ahead of print]

2.

Isolated high home systolic blood pressure in patients with type 2 diabetes is a prognostic factor for the development of diabetic nephropathy: KAMOGAWA-HBP study.

Kitagawa N, Ushigome E, Tanaka T, Hasegawa G, Nakamura N, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Kitagawa N, Hamaguchi M, Asano M, Yamazaki M, Fukui M.

Diabetes Res Clin Pract. 2019 Nov 8;158:107920. doi: 10.1016/j.diabres.2019.107920. [Epub ahead of print]

PMID:
31711859
3.

Severe Pneumonitis with Alveolar Hemorrhage Associated with Herbal Medicines: A Case Report.

Omori M, Saito Y, Miura Y, Tanaka T, Kashiwada T, Atsumi K, Hayashi H, Minegishi Y, Fujita K, Azuma A, Seike M, Gemma A.

J Nippon Med Sch. 2019 Dec 3;86(5):296-300. doi: 10.1272/jnms.JNMS.2019_86-504. Epub 2019 May 17.

4.

A 3-Dimensional Model of the Human Round Window Membrane.

Nomura Y, Tanaka T, Kobayashi H, Kimura Y, Soejima Y, Sawabe M.

Ann Otol Rhinol Laryngol. 2019 Jun;128(6_suppl):103S-110S. doi: 10.1177/0003489419833406.

PMID:
31092039
5.

Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study.

Okamura T, Ushigome E, Kitagawa N, Oyabu C, Tanaka T, Hasegawa G, Nakamura N, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Hamaguchi M, Asano M, Yamazaki M, Fukui M.

J Diabetes Investig. 2019 Nov;10(6):1543-1549. doi: 10.1111/jdi.13040. Epub 2019 May 7.

6.

Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.

Sugano T, Seike M, Funasaka Y, Yoshida M, Takayama R, Okamura K, Nakanishi A, Tanaka T, Takeuchi S, Noro R, Minegishi Y, Kubota K, Saeki H, Gemma A.

J Immunother Cancer. 2019 Feb 27;7(1):59. doi: 10.1186/s40425-019-0534-z.

7.

GABAergic and glutamatergic neurons in the brain regulate phase II of migrating motor contractions in the Suncus murinus.

Horita T, Koyama K, Takemi S, Tanaka T, Sakai T, Sakata I.

J Smooth Muscle Res. 2018;54(0):91-99. doi: 10.1540/jsmr.54.91.

8.

Cell-autonomous and redundant roles of Hey1 and HeyL in muscle stem cells: HeyL requires Hes1 to bind diverse DNA sites.

Noguchi YT, Nakamura M, Hino N, Nogami J, Tsuji S, Sato T, Zhang L, Tsujikawa K, Tanaka T, Izawa K, Okada Y, Doi T, Kokubo H, Harada A, Uezumi A, Gessler M, Ohkawa Y, Fukada SI.

Development. 2019 Feb 20;146(4). pii: dev163618. doi: 10.1242/dev.163618.

9.

Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations.

Aoyama J, Hayashi H, Yajima C, Takoi H, Tanaka T, Kashiwada T, Kokuho N, Terasaki Y, Nishikawa A, Gono T, Kuwana M, Saito Y, Abe S, Seike M, Gemma A.

Respir Med Case Rep. 2019 Jan 14;26:193-196. doi: 10.1016/j.rmcr.2019.01.012. eCollection 2019.

10.

Identification and characterization of an antimicrobial peptide, lysozyme, from Suncus murinus.

Takemi S, Ojima S, Tanaka T, Sakai T, Sakata I.

Cell Tissue Res. 2019 Jun;376(3):401-412. doi: 10.1007/s00441-019-02991-2. Epub 2019 Jan 24.

PMID:
30680460
11.

The Robo4-TRAF7 complex suppresses endothelial hyperpermeability in inflammation.

Shirakura K, Ishiba R, Kashio T, Funatsu R, Tanaka T, Fukada SI, Ishimoto K, Hino N, Kondoh M, Ago Y, Fujio Y, Yano K, Doi T, Aird WC, Okada Y.

J Cell Sci. 2019 Jan 2;132(1). pii: jcs220228. doi: 10.1242/jcs.220228.

12.

Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis.

Tozuka T, Sugano T, Noro R, Takano N, Hisakane K, Takahashi S, Tanaka T, Kashiwada T, Takeuchi S, Kunugi S, Minegishi Y, Saito Y, Kubota K, Seike M, Gemma A.

Oxf Med Case Reports. 2018 Oct 22;2018(11):omy094. doi: 10.1093/omcr/omy094. eCollection 2018 Nov.

13.

A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab.

Sugano T, Seike M, Noro R, Kaburaki S, Tozuka T, Takahashi A, Takano N, Tanaka T, Kashiwada T, Takeuchi S, Minegishi Y, Saito Y, Kubota K, Terasaki Y, Gemma A.

Onco Targets Ther. 2018 Sep 17;11:5879-5883. doi: 10.2147/OTT.S169321. eCollection 2018.

14.

Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.

Tanaka T, Kasai M, Kobayashi S.

Exp Cell Res. 2018 Sep 15;370(2):454-460. doi: 10.1016/j.yexcr.2018.07.009. Epub 2018 Jul 5.

PMID:
29981748
15.

Synthesis and Antimicrobial Activity of 2-Trifluoroacetonylbenzoxazole Ligands and Their Metal Complexes.

Watanabe G, Sekiya H, Tamai E, Saijo R, Uno H, Mori S, Tanaka T, Maki J, Kawase M.

Chem Pharm Bull (Tokyo). 2018;66(7):732-740. doi: 10.1248/cpb.c18-00158.

16.

β-Oxidation in ghrelin-producing cells is important for ghrelin acyl-modification.

Ikenoya C, Takemi S, Kaminoda A, Aizawa S, Ojima S, Gong Z, Chacrabati R, Kondo D, Wada R, Tanaka T, Tsuda S, Sakai T, Sakata I.

Sci Rep. 2018 Jun 15;8(1):9176. doi: 10.1038/s41598-018-27458-2.

17.

Elotuzumab-induced interstitial lung disease: the first case report.

Tanaka T, Saito Y, Kokuho N, Tamura H, Terasaki Y, Seike M, Gemma A.

Jpn J Clin Oncol. 2018 May 1;48(5):491-494. doi: 10.1093/jjco/hyy049.

PMID:
29635485
18.

ETV2-TET1/TET2 Complexes Induce Endothelial Cell-Specific Robo4 Expression via Promoter Demethylation.

Tanaka T, Izawa K, Maniwa Y, Okamura M, Okada A, Yamaguchi T, Shirakura K, Maekawa N, Matsui H, Ishimoto K, Hino N, Nakagawa O, Aird WC, Mizuguchi H, Kawabata K, Doi T, Okada Y.

Sci Rep. 2018 Apr 4;8(1):5653. doi: 10.1038/s41598-018-23937-8.

19.

Impact of masked hypertension on diabetic nephropathy in patients with type II diabetes: a KAMOGAWA-HBP study.

Ushigome E, Oyabu C, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Nakamura N, Oda Y, Asano M, Tanaka M, Yamazaki M, Fukui M.

J Am Soc Hypertens. 2018 May;12(5):364-371.e1. doi: 10.1016/j.jash.2018.02.005. Epub 2018 Mar 1.

PMID:
29548933
20.

Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column.

Kiyoshi M, Caaveiro JMM, Tada M, Tamura H, Tanaka T, Terao Y, Morante K, Harazono A, Hashii N, Shibata H, Kuroda D, Nagatoishi S, Oe S, Ide T, Tsumoto K, Ishii-Watabe A.

Sci Rep. 2018 Mar 2;8(1):3955. doi: 10.1038/s41598-018-22199-8.

Supplemental Content

Loading ...
Support Center